Telephone
1.952.818.8400
Address
400 Gateway Boulevard Burnsville, MN 55337
Description
Imricor Medical Systems, Inc. is a medical device company, which engages in the design, manufacture, and distribution of magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures. The firm offers the Advantage-MR EP Recorder/Stimulator system, an electrophysiology amplifier and recording system with integrated cardiac stimulator, Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter, and Vision-MR Dispersive Electrode, an ablation dispersive electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. The company was founded by Steven Wedan in 2006 and is headquartered in Burnsville, MN.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.41 - 1.71
Trade Value (12mth)
US$38,077.00
1 week
0%
1 month
4.26%
YTD
1.03%
1 year
191.09%
All time high
2.85
EPS 3 yr Growth
-9.20%
EBITDA Margin
%
Operating Cashflow
-$16m
Free Cash Flow Return
-206.50%
ROIC
-393.70%
Interest Coverage
-766.30
Quick Ratio
7.20
Shares on Issue (Fully Dilluted)
236m
HALO Sector
Healthcare
Next Company Report Date
25-Feb-26
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.05
Date | Announcements |
---|---|
17 April 25 |
CE Mark Approval for Advantage-MR under EU's MDR
×
CE Mark Approval for Advantage-MR under EU's MDR |
16 April 25 |
Change in substantial holding
×
Change in substantial holding |
16 April 25 |
Change in substantial holding from CGF
×
Change in substantial holding from CGF |
14 April 25 |
Notification regarding unquoted securities - IMR
×
Notification regarding unquoted securities - IMR |
11 April 25 |
Imricor Commences VISABL-VT Clinical Trial
×
Imricor Commences VISABL-VT Clinical Trial |
10 April 25 |
Notification of cessation of securities - IMR
×
Notification of cessation of securities - IMR |
10 April 25 |
Annual Report to shareholders
×
Annual Report to shareholders |
10 April 25 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
10 April 25 |
Notice of Annual Stockholders Meeting and CDI Voting Form
×
Notice of Annual Stockholders Meeting and CDI Voting Form |
01 April 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
01 April 25 |
Becoming a substantial holder from CGF
×
Becoming a substantial holder from CGF |
28 March 25 |
Cleansing Notice
×
Cleansing Notice |
28 March 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
27 March 25 |
Application for quotation of securities - IMR
×
Application for quotation of securities - IMR |
26 March 25 |
Application for quotation of securities - IMR
×
Application for quotation of securities - IMR |
20 March 25 |
Successful Completion of A$70 Million Capital Raise
×
Successful Completion of A$70 Million Capital Raise |
20 March 25 |
Proposed issue of securities - IMR
×
Proposed issue of securities - IMR |
20 March 25 |
Equity Raising Presentation
×
Equity Raising Presentation |
20 March 25 |
Reinstatement to Official Quotation
×
Reinstatement to Official Quotation |
19 March 25 |
Suspension from Quotation
×
Suspension from Quotation |
17 March 25 |
Trading Halt
×
Trading Halt |
07 March 25 |
S&P DJI Announces March 2025 Quarterly Rebalance
×
S&P DJI Announces March 2025 Quarterly Rebalance |
04 March 25 |
Submission of Second Module to FDA for PMA Products
×
Submission of Second Module to FDA for PMA Products |
27 February 25 |
Appendix 4E and FY24 Financial Accounts
×
Appendix 4E and FY24 Financial Accounts |
27 February 25 |
Imricor Releases FY24 Results
×
Imricor Releases FY24 Results |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.